TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34296667

Group type: EXPERIMENTAL
Intervention: Trained bystanders
Number of subjects: 96

Group type: COMPARATOR
Intervention: Dispatch doctors
Number of subjects: 96

Group type: COMPARATOR
Intervention: Medical dispatch assistants
Number of subjects: 96

Group type: COMPARATOR
Intervention: Untrained bystanders
Number of subjects: 96
Study: 33142467

Group type: EXPERIMENTAL
Intervention: 300 mg/kg SB
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: 600 mg/kg SB
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: 1,200 mg/kg SB
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: SB supplementation
Number of subjects: 288

Group type: COMPARATOR
Intervention: CON
Number of subjects: 288
Study: 33428625

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT) plus treatment as usual (TAU)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Wait List+TAU
Number of subjects: 256
Study: 32123205

Group type: EXPERIMENTAL
Intervention: Exercise training (n=23)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (n=22)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Exercise training (n=20)
Number of subjects: 45
Study: 35786581

Group type: EXPERIMENTAL
Intervention: Preemptive group (n=50) - administered 600 mg of ibuprofen 1 hour before the procedure
Number of subjects: 100

Group type: COMPARATOR
Intervention: Preventive group (n=50) - administered placebo preoperatively
Number of subjects: 100
Study: 34133859

Group type: EXPERIMENTAL
Intervention: Targeted hypothermia at 33°C
Number of subjects: 1900

Group type: COMPARATOR
Intervention: Targeted normothermia with early treatment of fever (body temperature, ≥37.8°C)
Number of subjects: 1900
Study: 32430027

Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA) treatment, 1 to 3 treatment cycles
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA) treatment
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (without fibroids)
Number of subjects: 26
Study: 34132234

Group type: EXPERIMENTAL
Intervention: 3D-printed drill guides
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modular guides
Number of subjects: 0

Group type: COMPARATOR
Intervention: Additional screw guiding methods (k-wire cannulated screws or modular guides)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular 3D-printed drill guides
Number of subjects: 0
Study: 34135954

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) injection
Number of subjects: 124

Group type: COMPARATOR
Intervention: Steroid injection
Number of subjects: 124
Study: 32222360

Group type: EXPERIMENTAL
Intervention: Traditional EQUIPPED with in-person academic detailing coupled with audit and feedback
Number of subjects: 2

Group type: COMPARATOR
Intervention: EQUIPPED dashboard with passive audit and feedback
Number of subjects: 2
Study: 32976205

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 2 μg/kg
Number of subjects: 156

Group type: COMPARATOR
Intervention: Oral midazolam 0.5 mg/kg
Number of subjects: 156

Group type: COMPARATOR
Intervention: 0.9% saline (placebo)
Number of subjects: 156
Study: 37045502

Group type: EXPERIMENTAL
Intervention: Genetic-guided P2Y12 inhibitor therapy (ticagrelor for LOF carriers, clopidogrel for noncarriers)
Number of subjects: 5302

Group type: COMPARATOR
Intervention: Conventional clopidogrel therapy
Number of subjects: 5302
Study: 34298402

Group type: COMPARATOR
Intervention: DPCP alone (Group D)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: DPCP combined with anthralin (Group D/A)
Number of subjects: 50
Study: 35536410

Group type: EXPERIMENTAL
Intervention: Active video games (AVGs) using Xbox‐Kinect‐360 device for 40 min/day, 3 days/week for 8 weeks plus airway clearance techniques (ACT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group applied ACT only
Number of subjects: 32
Study: 33850089

Group type: EXPERIMENTAL
Intervention: Noisy GVS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional GVS
Number of subjects: 24
Study: 32576229

Group type: EXPERIMENTAL
Intervention: galcanezumab 120 mg
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: galcanezumab 240 mg
Number of subjects: 2886

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2886
Study: 35400290

Group type: EXPERIMENTAL
Intervention: triceps surae PNF + PSA
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: quadriceps PNF + PSA
Number of subjects: 16
Study: 35596193

Group type: COMPARATOR
Intervention: Talking Control (TC) sessions
Number of subjects: 5
Study: 34420531

Group type: EXPERIMENTAL
Intervention: Maternal mid-upper arm circumference (MUAC)
Number of subjects: 2831

Group type: EXPERIMENTAL
Intervention: Maternal BMI
Number of subjects: 2831

Group type: EXPERIMENTAL
Intervention: Dietary diversity
Number of subjects: 2831

Group type: EXPERIMENTAL
Intervention: Meals per day
Number of subjects: 2831

Group type: EXPERIMENTAL
Intervention: Eating down and food aversion in pregnancy
Number of subjects: 2831

Group type: EXPERIMENTAL
Intervention: Neonatal z-scores of length-for-age (LAZ)
Number of subjects: 2831

Group type: EXPERIMENTAL
Intervention: Neonatal z-scores of weight-for-age (WAZ)
Number of subjects: 2831

Group type: EXPERIMENTAL
Intervention: Neonatal z-scores of weight-for-length (WLZ)
Number of subjects: 2831

Group type: EXPERIMENTAL
Intervention: Neonatal head circumference-for-age (HCAZ)
Number of subjects: 2831
Study: 34536258

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acustimulation (TEA)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham-TEA
Number of subjects: 42
Study: 32005781

Group type: EXPERIMENTAL
Intervention: arthroscopic tenotomy of the long head of the biceps tendon
Number of subjects: 172
Study: 36328211

Group type: EXPERIMENTAL
Intervention: Counselling intervention (one-month counselling once-a-year for 3 years)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counselling intervention
Number of subjects: 0
Study: 32156136

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 0
Study: 35381849

Group type: EXPERIMENTAL
Intervention: Selenium yeast (200 µg/day) and coenzyme Q10 (200 mg/day)
Number of subjects: 443

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 443
Study: 33840387

Group type: EXPERIMENTAL
Intervention: TURP or Thulium vapoenucleation (ThuP)
Number of subjects: 2363
Study: 32497605

Group type: EXPERIMENTAL
Intervention: Oxygen supplementation (10 L/min) for long durations (≥75th percentile)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Oxygen supplementation (10 L/min) for short durations (<75th percentile)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 99
Study: 35605429

Group type: EXPERIMENTAL
Intervention: PRI-724 (280 mg/m2/4 h) administered intravenously twice weekly for 12 weeks
Number of subjects: 27
Study: 33631372

Group type: EXPERIMENTAL
Intervention: Cognitive Reserve EnhAncement ThErapy (CREATE)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Supportive approach
Number of subjects: 173

Group type: COMPARATOR
Intervention: Community comparison group (CC)
Number of subjects: 173
Study: 35674667

Group type: EXPERIMENTAL
Intervention: Pro-poor sanitation subsidy program
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control (no subsidy)
Number of subjects: 109
Study: 32472357

Group type: EXPERIMENTAL
Intervention: Ambrisentan 10 mg (generic product)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Volibris® (ambrisentan) 10 mg (reference product)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both treatments (Ambrisentan 10 mg and Volibris® 10 mg)
Number of subjects: 26
Study: 35172440

Group type: EXPERIMENTAL
Intervention: Platelet rich plasma
Number of subjects: 200

Group type: COMPARATOR
Intervention: Hyaluronic acid
Number of subjects: 200
Study: 34363764

Group type: EXPERIMENTAL
Intervention: 1.8 mL of 0.5% bupivacaine hydrochloride + 1 mL/4 mg dexamethasone (Group A1)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine hydrochloride + 1 mL/4 mg dexamethasone (Group B1)
Number of subjects: 68

Group type: COMPARATOR
Intervention: 1.8 mL of 0.5% bupivacaine hydrochloride (Group A)
Number of subjects: 68

Group type: COMPARATOR
Intervention: 0.75% ropivacaine hydrochloride (Group B)
Number of subjects: 68
Study: 34011358

Group type: EXPERIMENTAL
Intervention: Artefenomel (800 mg) plus ferroquine (400 mg to 1200 mg)
Number of subjects: 373
Study: 32764077

Group type: EXPERIMENTAL
Intervention: Trough-coupled tACS
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Amplitude-modulated tACS
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Peak-coupled tACS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control tACS (80-Hz tACS continuously superimposed over 4-Hz tACS)
Number of subjects: 24
Study: 35510765

Group type: EXPERIMENTAL
Intervention: Cysteamine 5% cream
Number of subjects: 65

Group type: COMPARATOR
Intervention: Hydroquinone 4%/ascorbic acid 3% cream (HC)
Number of subjects: 65
Study: 34976662

Group type: EXPERIMENTAL
Intervention: Initial support via telephone and e-mail (two phone calls and one e-mail over the first eight weeks)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Usual practice (self-directed use)
Number of subjects: 356
Study: 35303160

Group type: EXPERIMENTAL
Intervention: Treadmill walking at 40% of age-predicted max heart rate (40HR)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Treadmill walking at 60% of age-predicted max heart rate (60HR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Seated rest (NOEX)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All interventions (40HR, 60HR, NOEX)
Number of subjects: 30
Study: 32106548

Group type: EXPERIMENTAL
Intervention: Standardized bilberry extract (SBE) 240 mg once daily for 12 weeks
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 34169518

Group type: EXPERIMENTAL
Intervention: Future as older adult thinking
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 144
Study: 32892297

Group type: EXPERIMENTAL
Intervention: Protect Your Family (PYF) behavioral intervention with male partners present
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control program with male partners present
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Protect Your Family (PYF) behavioral intervention without male partners present
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control program without male partners present
Number of subjects: 0
Study: 33201232

Group type: EXPERIMENTAL
Intervention: α‐cyclodextrin
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: hydrolyzed ginseng
Number of subjects: 401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 401
Study: 34002910

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF) treatment
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 33377960

Group type: EXPERIMENTAL
Intervention: Muscular tissue oxygen saturation‐guided care (n = 400)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Usual care (n = 399)
Number of subjects: 800
Study: 35039269

Group type: EXPERIMENTAL
Intervention: Qingfei Huatan Huoxue Decoction combined with azithromycin
Number of subjects: 155

Group type: COMPARATOR
Intervention: Azithromycin (control group)
Number of subjects: 155
Study: 32969605

Group type: EXPERIMENTAL
Intervention: Novel risk score for predicting cardiovascular complications
Number of subjects: 1207
Study: 34456324

Group type: EXPERIMENTAL
Intervention: Video training (n=121)
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Culturally tailored, facilitator-led training (n=136)
Number of subjects: 339

Group type: COMPARATOR
Intervention: Attention-placebo training focused on heat-related illness (n=82)
Number of subjects: 339
Study: 34022835

Group type: EXPERIMENTAL
Intervention: AIDS Fighter · Health Defense game-based intervention
Number of subjects: 0
Study: 32422871

Group type: EXPERIMENTAL
Intervention: Campus forest therapy program
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study: 33993740

Group type: EXPERIMENTAL
Intervention: Fruquintinib plus best supportive care
Number of subjects: 687

Group type: COMPARATOR
Intervention: Placebo plus best supportive care
Number of subjects: 687
Study: 33130619

Group type: EXPERIMENTAL
Intervention: Timing of intervention for acute spinal cord injury (aSCI)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Delayed diagnosis and intervention
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Plaintiffs' awards in cases with disclosed amounts
Number of subjects: 163
Study: 35059248

Group type: EXPERIMENTAL
Intervention: LMET + DPP4i treatment (low-dose metformin 750 mg/day + vildagliptin 100 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: HMET treatment (high-dose metformin 1500 mg/day)
Number of subjects: 20
Study: 33842037

Group type: EXPERIMENTAL
Intervention: Dry Needling (DN)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham Dry Needling (SHAM)
Number of subjects: 11
Study: 35103905

Group type: EXPERIMENTAL
Intervention: Locally produced ready‐to‐use therapeutic food (L‐RUTF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard ready‐to‐use therapeutic food (S‐RUTF)
Number of subjects: 0
Study: 33389689

Group type: EXPERIMENTAL
Intervention: Molar incisor hypomineralisation (MIH)
Number of subjects: 1047

Group type: COMPARATOR
Intervention: Health and demographic characteristics
Number of subjects: 1047
Study: 35298865

Group type: EXPERIMENTAL
Intervention: Collagen matrix with deproteinized bovine bone mineral containing 10% collagen (DBBM-C)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Natural healing (control group)
Number of subjects: 30
Study: 35183157

Group type: EXPERIMENTAL
Intervention: Balance Body Tape (BBT) treatment for 3 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 26
Study: 35594559

Group type: EXPERIMENTAL
Intervention: Isatuximab plus carfilzomib and dexamethasone (Isa‐Kd)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Carfilzomib and dexamethasone (Kd)
Number of subjects: 302
Study: 33080012

Group type: EXPERIMENTAL
Intervention: Hypothermia
Number of subjects: 162

Group type: COMPARATOR
Intervention: Normothermia
Number of subjects: 162
Study: 33099278

Group type: EXPERIMENTAL
Intervention: VA-ECMO with LV unloading strategies
Number of subjects: 0

Group type: COMPARATOR
Intervention: VA-ECMO without LV unloading strategies
Number of subjects: 0
Study: 35684098

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation during a 12-week lifestyle program
Number of subjects: 44

Group type: COMPARATOR
Intervention: Lifestyle program without Vitamin D supplementation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Normal-weight adolescents (control group)
Number of subjects: 44
Study: 34839601

Group type: EXPERIMENTAL
Intervention: Citrate group
Number of subjects: 68

Group type: COMPARATOR
Intervention: Heparin group
Number of subjects: 68
Study: 33779320

Group type: EXPERIMENTAL
Intervention: AIM HI (An Individualized Mental Health Intervention for ASD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 0
Study: 33256758

Group type: EXPERIMENTAL
Intervention: Single screening and treatment (SST) strategy using malaria rapid diagnostic tests (RDT)
Number of subjects: 1845
Study: 36094502

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (INT) - 1 day/week of nutrition and health education and 3 days/week of physical activity for 6 months.
Number of subjects: 117

Group type: COMPARATOR
Intervention: Usual care control (UCC) - 2 visits with a pediatric endocrinologist and a bilingual, bicultural registered dietitian.
Number of subjects: 117
Study: 36130753

Group type: EXPERIMENTAL
Intervention: Combined low energy diet (800-900 kcal/day) with meal replacement products and supervised exercise training (aerobic and resistance) three times weekly during the intensive phase (12 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care (control arm)
Number of subjects: 100
Study: 32345700

Group type: EXPERIMENTAL
Intervention: Clinical pharmacist intervention targeting drug-related problems (DRPs), initiated within a week of discharge, involving medical chart reviews, phone interviews, and medication reviews.
Number of subjects: 700

Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 700
Study: 34984964

Group type: EXPERIMENTAL
Intervention: Older adult client in good health
Number of subjects: 488

Group type: COMPARATOR
Intervention: Older adult client in poor health
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Higher ageist attitudes
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Higher aging anxiety
Number of subjects: 488
Study: 34682655

Group type: EXPERIMENTAL
Intervention: IMI psychosomatic aftercare
Number of subjects: 142

Group type: COMPARATOR
Intervention: Face-to-Face (F2F) psychosomatic aftercare
Number of subjects: 142
Study: 32414185

Group type: EXPERIMENTAL
Intervention: PMA-zeolite (Multizeo Med)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 36409639

Group type: EXPERIMENTAL
Intervention: Gentamicin intravesical instillation
Number of subjects: 370

Group type: COMPARATOR
Intervention: Sham instillation
Number of subjects: 370
Study: 33238805

Group type: EXPERIMENTAL
Intervention: #ad
Number of subjects: 200

Group type: COMPARATOR
Intervention: #sponsored
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: #ad and #sponsored
Number of subjects: 200
Study: 36001196

Group type: EXPERIMENTAL
Intervention: PEERS® intervention (hybrid mode)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Waitlist Control Group
Number of subjects: 29
Study: 34384499

Group type: COMPARATOR
Intervention: Single oral dose of 240, 480, 960, or 1440 mg ES16001 (SAD study)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Once daily doses of 480 or 960 mg ES16001 for 5 days (MAD study)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (SAD and MAD studies)
Number of subjects: 48
Study: 33522565

Group type: EXPERIMENTAL
Intervention: Individualized exercise program (2 daily sessions of 20 minutes for 5-7 days)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 297
Study: 33392869

Group type: EXPERIMENTAL
Intervention: Subharmonic imaging (SHI) using Sonazoid contrast agent
Number of subjects: 131
Study: 32090660

Group type: EXPERIMENTAL
Intervention: Neurofeedback (NFB) treatment, 40 sessions targeting very slow cortical potential range, addressing inhibitory deficits through right and left prefrontal training.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (sham treatment).
Number of subjects: 20
Study: 34389850

Group type: EXPERIMENTAL
Intervention: Cluster randomized trial design
Number of subjects: 0
Study: 33523186

Group type: EXPERIMENTAL
Intervention: Low-fat vegan diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 35568668

Group type: EXPERIMENTAL
Intervention: Mid-Urethral Sling (MUS) surgery
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Peri-urethral bulking injections (PBI) with polydimethylsiloxane Urolastic (PDMS-U)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Both MUS and PBI
Number of subjects: 259
Study: 33740415

Group type: EXPERIMENTAL
Intervention: Aggressive hydration plus rectal NSAIDs (100 mg diclofenac or indomethacin); aggressive hydration comprised 20 mL/kg intravenous Ringer's lactate solution within 60 min from the start of ERCP, followed by 3 mL/kg per h for 8 h.
Number of subjects: 826

Group type: COMPARATOR
Intervention: Control group received rectal NSAIDs (100 mg diclofenac or indomethacin) alone with normal intravenous saline (maximum of 1·5 mL/kg per h and 3 L per 24 h).
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Aggressive hydration plus rectal NSAIDs
Number of subjects: 826

Group type: COMPARATOR
Intervention: Control group (rectal NSAIDs alone)
Number of subjects: 826
Study: 36048234

Group type: EXPERIMENTAL
Intervention: Arthroscopic capsular release (ACR)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Manipulation under anaesthesia (MUA)
Number of subjects: 85
Study: 32584199

Group type: EXPERIMENTAL
Intervention: COVID-19 infection in children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multisystem inflammatory syndrome in children (MIS-C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical trials for therapeutics and vaccine development
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pandemic control measures
Number of subjects: 0
Study: 32769625

Group type: EXPERIMENTAL
Intervention: Online cognitive training intervention (8-week duration, combining webinar classes and online computer game training)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Online cognitive training intervention
Number of subjects: 10
Study: 35035842

Group type: EXPERIMENTAL
Intervention: Standard Operating Procedure (SOP) for VTE prevention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine nursing (Control Group)
Number of subjects: 120
Study: 32061707

Group type: EXPERIMENTAL
Intervention: Warning label
Number of subjects: 1997

Group type: EXPERIMENTAL
Intervention: Health star rating
Number of subjects: 1997

Group type: EXPERIMENTAL
Intervention: Traffic light labelling
Number of subjects: 1997

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1997

Group type: EXPERIMENTAL
Intervention: Disease risk reduction claim
Number of subjects: 1997

Group type: EXPERIMENTAL
Intervention: Nutrient content claim
Number of subjects: 1997
Study: 35114798

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure lowering (<130 mm Hg)
Number of subjects: 3019

Group type: COMPARATOR
Intervention: Standard systolic blood pressure lowering (130-149 mm Hg)
Number of subjects: 3019
Study: 32068571

Group type: EXPERIMENTAL
Intervention: Sevoflurane sedation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Propofol sedation
Number of subjects: 100
Study: 35851679

Group type: EXPERIMENTAL
Intervention: BCM Diät™ (diet 1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Optifast™ (diet 2)
Number of subjects: 90
Study: 32027191

Group type: EXPERIMENTAL
Intervention: Gestational age at delivery ≥32 weeks
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Protocol-based management
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Use of magnesium sulphate
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Gestational age at diagnosis ≥28 weeks
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Birthweight ≥1000 g
Number of subjects: 51
Study: 33946255

Group type: EXPERIMENTAL
Intervention: PAP treatment with enhanced support from a physiotherapist
Number of subjects: 98